Study measures patient rankings of third-line OAB treatments

“We wanted to help provide an understanding of what factors guide patient choice of third line therapy for overactive bladder,” says Anjali Kapur, MD.

In this video, Anjali Kapur, MD, discusses the background and notable findings of the recent Neurourology and Urodynamics paper, “An analysis of factors that influence patient preference of third-line therapy for overactive bladder.” Kapur is a urology resident at Renaissance School of Medicine at Stony Brook University, Stony Brook, New York.

Related Content:

OAB and IncontinenceResidents Corner
Urology residency program director discusses preference signaling process
Dr. North shares 2021 AUA census results on residents and fellows
Vibegron as crushed tablet found safe, efficacious in OAB